Novoray Corporation (688300) - Total Liabilities

Latest as of September 2025: CN¥585.16 Million CNY ≈ $85.63 Million USD

Based on the latest financial reports, Novoray Corporation (688300) has total liabilities worth CN¥585.16 Million CNY (≈ $85.63 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688300 cash flow conversion to assess how effectively this company generates cash.

Novoray Corporation - Total Liabilities Trend (2012–2024)

This chart illustrates how Novoray Corporation's total liabilities have evolved over time, based on quarterly financial data. Check Novoray Corporation (688300) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Novoray Corporation Competitors by Total Liabilities

The table below lists competitors of Novoray Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Liechtensteinische Landesbank Aktiengesellschaft STU:LLS1	Germany	€25.96 Billion
Shenzhen Jove Enterprise Co. Ltd. SHE:300814	China	CN¥1.54 Billion
Asker Healthcare ST:ASKER	Sweden	Skr9.43 Billion
Hisense Kelon Electrical Holdings Co Ltd SHE:000921	China	CN¥51.29 Billion
Fujian Sunner Development Co Ltd SHE:002299	China	CN¥12.12 Billion
Beijing Capital Co Ltd SHG:600008	China	CN¥81.85 Billion
Guangzhou Zhujiang Brewery Co Ltd SHE:002461	China	CN¥5.35 Billion
H B Fuller Company NYSE:FUL	USA	$3.18 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Novoray Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Novoray Corporation worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novoray Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novoray Corporation (2012–2024)

The table below shows the annual total liabilities of Novoray Corporation from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥464.29 Million ≈ $67.94 Million	+14.00%
2023-12-31	CN¥407.26 Million ≈ $59.60 Million	+32.40%
2022-12-31	CN¥307.59 Million ≈ $45.01 Million	+45.64%
2021-12-31	CN¥211.19 Million ≈ $30.90 Million	+64.20%
2020-12-31	CN¥128.62 Million ≈ $18.82 Million	+0.82%
2019-12-31	CN¥127.58 Million ≈ $18.67 Million	+35.45%
2018-12-31	CN¥94.19 Million ≈ $13.78 Million	-14.46%
2017-12-31	CN¥110.11 Million ≈ $16.11 Million	+35.19%
2016-12-31	CN¥81.45 Million ≈ $11.92 Million	+11.95%
2015-12-31	CN¥72.76 Million ≈ $10.65 Million	-10.24%
2014-12-31	CN¥81.05 Million ≈ $11.86 Million	-28.12%
2013-12-31	CN¥112.77 Million ≈ $16.50 Million	+146.34%
2012-12-31	CN¥45.78 Million ≈ $6.70 Million	--

About Novoray Corporation

SHG:688300 China Specialty Chemicals

Market Cap

$3.33 Billion

CN¥22.77 Billion CNY

Market Cap Rank

#4669 Global

#871 in China

Share Price

CN¥94.29

Change (1 day)

-0.71%

52-Week Range

CN¥38.16 - CN¥99.96

All Time High

CN¥99.96